Autolus Therapeutics stock slide on pricing $150.0M ADS offering
Autolus Therapeutics (NASDAQ:AUTL) shares sank 23.1% after-hours after the firm has priced its previously announced underwritten public offering of 75M American Depositary Shares representing 75M ordinary shares at a public offering price of $2.00/ADS, for total gross proceeds of $150.0M.
All ADSs sold in the offering were offered by Autolus.
Underwriters are granted a 30-day option to purchase up to an additional 11.25M ADSs at the public offering price.
Offering is expected to close on December 13, 2022.